New Search

If you are not happy with the results below please do another search

1 search result for:

1

Novigenix-led consortium secures Eurostars funding to develop predictive immune checkpoint inhibitor test

Novigenix SA Switzerland, a pioneer in immuno-transcriptomics for precision medicine, will lead a consortium, including PamGene International and Radboud University (The Netherlands), to develop a blood based multi-omics test to predict response to immune checkpoint inhibitors in cancer. The consortium has been awarded a grant up to €1 million under the Eurostars programme.